Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Oct. 2, 2025. Document 2025-19348. Updated Nov. 18, 2026.
- What it does
The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- What happens next and when
Comments must be submitted electronically or postmarked on or before November 3, 2025.
The agency's dates, word for word.
The record as published
| Document number | 2025-19348 |
|---|---|
| Action | Notice of proposed rulemaking. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | Oct. 2, 2025 |
| Comments close | Nov. 3, 2025 |
| Docket | DEA-2025-0555 |
Source: the Federal Register (public domain). The document in the Federal Register